C M West
Overview
Explore the profile of C M West including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
181
Citations
2089
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Price J, Garcez K, Hughes C, Lee L, Mistry H, Motamedi-Ghahfarokhi G, et al.
Oral Oncol
. 2024 Dec;
161():107138.
PMID: 39708715
Introduction: Studies reported inferior outcomes when radiotherapy starts >6-8 weeks post-surgery for head and neck squamous cell carcinoma (HNSCC) but are limited due to time variable dichotomization. We assessed the...
2.
Price J, West C, Mistry H, Betts G, Bishop P, Kennedy J, et al.
Oral Oncol
. 2021 Feb;
115:105140.
PMID: 33548862
Purpose: For oropharynx squamous cell carcinoma (OPSCC) this study aimed to: (i) compare 5-year overall survival (OS) stratification by AJCC/UICC TNM versions 7 (TNMv7) and 8 (TNMv8), (ii) determine whether...
3.
West C, Slevin F
Clin Oncol (R Coll Radiol)
. 2019 Jul;
31(9):595-599.
PMID: 31301956
No abstract available.
4.
Brothwell M, West C, Dunning A, Burnet N, Barnett G
Clin Oncol (R Coll Radiol)
. 2019 Mar;
31(5):319-325.
PMID: 30914148
Most radiogenomics studies investigate how genetic variation can help to explain the differences in early and late radiotherapy toxicity between individuals. The field of radiogenomics in photon beam therapy has...
5.
Joseph N, Dovedi S, Thompson C, Lyons J, Kennedy J, Elliott T, et al.
Ann Oncol
. 2015 Nov;
27(2):294-9.
PMID: 26578732
Background: Pre-treatment lymphocytopaenia may result from cytokines secreted by the tumour microenvironment in association with aggressive tumour biology. We sought to establish the prognostic significance of lymphocytopaenia in muscle-invasive and...
6.
Hunter B, Eustace A, Irlam J, Valentine H, Denley H, Oguejiofor K, et al.
Br J Cancer
. 2014 Jun;
111(3):437-43.
PMID: 24937673
Background: The addition of carbogen and nicotinamide (CON) to radiotherapy (RT) improves overall survival in invasive bladder cancer. We explored whether expression of the hypoxia marker hypoxia-inducible factor-1α (HIF-1α) alone...
7.
MCREE P, West C, MCLENDON J
UCRL US At Energy Comm
. 2014 Feb;
59:1-99.
PMID: 24547340
No abstract available.
8.
Mirza A, Brown M, McNulty C, Valentine J, Annesley A, Galloway S, et al.
Gastroenterol Res Pract
. 2013 Mar;
2013:502153.
PMID: 23533389
Aims and Background. Patients in the United Kingdom with operable gastric and gastro-oesophageal junction (GOJ) tumours receive neoadjuvant chemotherapy. Our aim was to study the expression of thymidylate synthase (TS)...
9.
Mirza A, Foster L, Valentine H, Welch I, West C, Pritchard S
Dis Esophagus
. 2012 Oct;
27(5):485-92.
PMID: 23082947
Epithelial to mesenchymal transition (EMT) promotes tumor progression and invasion. As no study has focused on gastroesophageal junction (GEJ) tumors, the expression of three EMT-related proteins (S100A4, vimentin, and Snail1)...
10.
Buffa F, Harris A, West C, Miller C
Br J Cancer
. 2010 Jan;
102(2):428-35.
PMID: 20087356
Background: There is a need to develop robust and clinically applicable gene expression signatures. Hypoxia is a key factor promoting solid tumour progression and resistance to therapy; a hypoxia signature...